Day: January 29, 2024

Total of $100,000 Awarded to Five Patient Advocacy Organizations to Support Communications and Community Outreach SOUTH SAN FRANCISCO, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its sixth annual Communications Grant Program, intended to support increased capacity in communications, awareness building and community engagement. Five grants in the amount of $20,000 each were awarded this year to patient advocacy organizations focused on the hypertrophic cardiomyopathy (HCM), heart failure and amyotrophic lateral sclerosis (ALS) communities. The grants will support projects to increase access to resources, grow organizational reach and launch educational programs. “Our unwavering commitment is first and foremost to patients which we demonstrate every day by advancing...

Figure 1Process Plant Foundations and Temporary Facilities – October 2023Figure 2Process Plant Foundations and Temporary Facilities – January 2024MilestoneMilestoneHALIFAX, Nova Scotia, Jan. 29, 2024 (GLOBE NEWSWIRE) — Erdene Resource Development Corp. (TSX:ERD; MSE:ERDN) (“Erdene” or the “Company“) is pleased to announce the commencement of full construction at the high-grade, open-pit Bayan Khundii Gold Project (“Bayan Khundii”, “BK” or “Project”) in southwestern Mongolia and the close of the investment by Mongolian Mining Corporation (“MMC”) as part of the Strategic Alliance Agreement (“SAA”) to develop the Khundii Minerals District. Peter Akerley, Erdene’s President and CEO stated, “We are extremely pleased to announce the formal commencement of construction at the Bayan...

Results from two positive Phase 3 studies point to Tonmya’s (TNX-102 SL) potential as a new first-line medicine for chronic use in managing fibromyalgia, a debilitating condition suffered by 6-12 million adults in the U.S. New Drug Application (NDA) submission to the FDA planned for second half of 2024 under the 505(b)(2) regulatory pathway CHATHAM, N.J., Jan. 29, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that the U.S. Food and Drug Administration (FDA) has conditionally accepted the trade name, Tonmya™, for the Company’s drug product candidate TNX-102 SL for the management of fibromyalgia. Tonmya is a patented sublingual tablet formulation of cyclobenzaprine...

WALTHAM, Mass., Jan. 29, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the appointment of Jason A. Amello as Chief Financial Officer. Mr. Amello, a senior finance executive, brings to TScan nearly three decades of expertise in financial strategy, business development, and operations in the biotechnology industry. “We are pleased to welcome Jason to TScan at such an exciting time as we continue to make significant progress across both our heme and solid tumor programs, with multiple important milestones on the horizon,” said Gavin MacBeath, Ph.D., Chief Executive Officer. “Jason’s corporate experience, having held several prior...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 29, 2024 (GLOBE NEWSWIRE) — Cartier Silver Corporation (CSE:CFE) (“Cartier Silver” or the “Company”) is pleased to announce that it is proceeding with a non-brokered private placement (the “Private Placement”) for proceeds of up to $2 million. Private Placement The Private Placement will consist of up to 8,000,000 units of Cartier Silver at a price of $0.25 per unit (“Units”) for gross proceeds of up to $2 million. Each Unit will consist of one common share in the capital of Cartier Silver (a “Common Share”) and one half of one Common Share purchase warrant (each whole, a “Warrant”). Each Warrant will entitle the holder to purchase one Common Share at a price of $0.50 per share for a term of 24 months following...

CINCINNATI, Jan. 29, 2024 (GLOBE NEWSWIRE) — GRIID Infrastructure Inc. (“GRIID” or the “Company”) (NASDAQ: GRDI) (NEO: GRDI), an American infrastructure company that operates vertically integrated bitcoin mining facilities leveraging low-cost, low-carbon energy, announced that the company will begin trading its common stock and warrants on Nasdaq Global Market (“Nasdaq”) today. The company’s common stock will trade under the ticker symbol “GRDI,” and the warrants will trade under the ticker symbol “GRDIW”. The Company’s common stock will continue to trade on Cboe Canada, formerly known as the NEO Exchange, under the ticker symbol “GRDI.” GRIID is a purpose-built bitcoin mining company, founded in 2018, that has operated bitcoin mining facilities since 2019. GRIID has built long-term power relationships securing affordable, reliable,...

VANCOUVER, British Columbia, Jan. 29, 2024 (GLOBE NEWSWIRE) — United Lithium Corp. (“United” or the “Company”) (CSE: ULTH; OTC: ULTHF; FWB: 0UL) is pleased to announce that Anoop Prihar has joined the Company as Vice President Corporate Development. Mr. Prihar has over twenty-five years of experience as an institutional sell-side equity analyst with a focus on the mining sector. The Company has also commenced a Scandinavian focused marketing and awareness campaign to introduce the investment community to United’s local lithium projects in Sweden and Finland. Appointment of Vice President Corporate Development Mr. Prihar has worked as an institutional sell-side equity analyst for over twenty-five years at Stifel GMP and Eight Capital in Toronto, Canada. During this time, he covered a variety of sectors including: Metals and Mining,...

In January 2024, CEO Ted Goldthorpe appointed to Marret Asset Management’s (“Marret”) Board of Directors Marret is a leading Canadian specialist credit manager with approximately C$5 billion assets under advisory Mount Logan purchased a strategic minority stake in Marret during June 2023 Separately, Mount Logan announced completion of opportunistic $18.8 million debenture units offering NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 29, 2024 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan,” “our,” “we,” or the “Company”) is pleased to announce the appointment of Mount Logan’s CEO, Ted Goldthorpe, to Marret’s Board of Directors during January 2024. Marret is a prominent Canadian asset manager specializing in global fixed-income investing and alternative...